R.I.-based company’s CVS Caremark® pharmacy benefit management business. He previously was named interim president in December 2024. “Ed’s ability to build and grow a strong team culture ...

CVS Health has named Ed DeVaney president of the company’s Caremark pharmacy benefit management business. Named interim president in December 2024, he will report to Prem Shah, group president o ...

CVS Health has named Ed DeVaney as president of its pharmacy benefit manager, CVS Caremark. DeVaney has served as interim president of Caremark since December 2024. The president's role was ...

named Ed DeVaney president of the company's CVS Caremark pharmacy benefit management business. He was named interim president in December 2024. DeVaney will report to Prem Shah, group president ...

Jan 23 (Reuters) - Oklahoma's attorney general has accused CVS's (CVS.N), opens new tab Caremark pharmacy benefit manager unit of under-reimbursing pharmacies for prescription drugs. The complaint ...

House Republicans launched an antitrust investigation Thursday into whether CVS Caremark, a leading pharmacy ... All republished articles must include our logo, our reporter’s byline and their ...

The case accuses UnitedHealth Group’s Optum unit, CVS Health’s CVS Caremark and Cigna’s Express Scripts of unfairly excluding lower cost insulin products from lists of drugs covered by insurers.

AM Best has assigned a financial strength rating of A (Excellent) and a long-term issuer credit rating of “a” (Excellent) to Bermudian-based CVS Caremark Indemnity Ltd. The outlook assigned to ...

In a STAT-obtained settlement document, CVS Caremark, one of the largest pharmacy benefits managers in the country, has agreed to pay the Illinois attorney general's office the $45 million tab.

This has led to calls for serious reform of PBMs and how important a role that they play in the industry. CVS Caremark recently issued a statement affirming its position and viewpoint on the role of ...

CVS Caremark pledges to accelerate transparency, drive to lowest net cost prescription drugs, strengthen pharmacy relations, and deliver the best clinical care in pharmacy The Caremark Client and ...

The move is part of CVS Caremark’s efforts to expand the adoption of biosimilars. As it stands, the U.S. biosimilar market is expected to grow from less than $10 billion in 2022 to more than $ ...